Last reviewed · How we verify
AZD9833 film-coated tablet B Dose 1 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
AZD9833 film-coated tablet B Dose 1 (AZD9833 film-coated tablet B Dose 1) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| AZD9833 film-coated tablet B Dose 1 TARGET | AZD9833 film-coated tablet B Dose 1 | AstraZeneca | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- AZD9833 film-coated tablet B Dose 1 CI watch — RSS
- AZD9833 film-coated tablet B Dose 1 CI watch — Atom
- AZD9833 film-coated tablet B Dose 1 CI watch — JSON
- AZD9833 film-coated tablet B Dose 1 alone — RSS
Cite this brief
Drug Landscape (2026). AZD9833 film-coated tablet B Dose 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/azd9833-film-coated-tablet-b-dose-1. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab